Taika Capital’s Encompass Health EHC Stock Holding History

Taika Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,798	Closed	-$351K	–	23
2024 Q4	$351K	Buy	+3,798	New	+$373K	0.27%	77

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Taika Capital's EHC Position: Q1 2025 in Review

Taika Capital sold out of Encompass Health (EHC) in Q1 2025, closing a stake of 3,798 shares — an estimated $351K sold.

Taika Capital first reported a position in EHC in Q4 2024 and held it in 1 quarter. The position peaked at $351K in Q4 2024. 537 funds tracked by Wall St. Rank hold EHC as of Q1 2025.

Taika Capital reported no remaining Encompass Health position as of Q1 2025 after selling out during the quarter.
Taika Capital sold 3,798 Encompass Health shares in Q1 2025, an estimated $351K.
Taika Capital first reported a position in Encompass Health in Q4 2024 and held it in 1 quarter.
Taika Capital's Encompass Health position peaked at $351K in Q4 2024.
537 funds tracked by Wall St. Rank held Encompass Health as of Q1 2025.

Based on Taika Capital's 13F filing for Q1 2025.